reweave: merge 18 files via frontmatter union [auto]
This commit is contained in:
Teleo Agents
parent
d709531818
commit
57157ba94d
18 changed files with 133 additions and 22 deletions
|
|
@ -10,9 +10,23 @@ agent: clay
|
|||
scope: structural
|
||||
sourcer: CoinDesk Research
|
||||
related_claims: ["[[community-owned-IP-has-structural-advantage-in-human-made-premium-because-provenance-is-inherent-and-legible]]", "[[fanchise management is a stack of increasing fan engagement from content extensions through co-creation and co-ownership]]"]
|
||||
related: ["Community-owned IP theory preserves concentrated creative execution by separating strategic funding decisions from operational creative development", "pudgy-penguins-inverts-web3-ip-strategy-by-prioritizing-mainstream-distribution-before-community-building", "Negative CAC model inverts IP economics by treating merchandise as profitable user acquisition rather than monetization endpoint", "community-owned-ip-is-community-branded-but-not-community-governed-in-flagship-web3-projects", "nft-holder-ip-licensing-converts-speculation-to-evangelism-through-revenue-sharing", "nft-royalty-mechanisms-create-permanent-financial-alignment-between-holders-and-ip-quality", "royalty-based-financial-alignment-may-be-sufficient-for-commercial-ip-success-without-narrative-depth", "community-owned-ip-theory-preserves-concentrated-creative-execution-through-strategic-operational-separation"]
|
||||
reweave_edges: ["Community-owned IP theory preserves concentrated creative execution by separating strategic funding decisions from operational creative development|related|2026-04-17", "pudgy-penguins-inverts-web3-ip-strategy-by-prioritizing-mainstream-distribution-before-community-building|related|2026-04-17", "Negative CAC model inverts IP economics by treating merchandise as profitable user acquisition rather than monetization endpoint|related|2026-04-24"]
|
||||
related:
|
||||
- Community-owned IP theory preserves concentrated creative execution by separating strategic funding decisions from operational creative development
|
||||
- pudgy-penguins-inverts-web3-ip-strategy-by-prioritizing-mainstream-distribution-before-community-building
|
||||
- Negative CAC model inverts IP economics by treating merchandise as profitable user acquisition rather than monetization endpoint
|
||||
- community-owned-ip-is-community-branded-but-not-community-governed-in-flagship-web3-projects
|
||||
- nft-holder-ip-licensing-converts-speculation-to-evangelism-through-revenue-sharing
|
||||
- nft-royalty-mechanisms-create-permanent-financial-alignment-between-holders-and-ip-quality
|
||||
- royalty-based-financial-alignment-may-be-sufficient-for-commercial-ip-success-without-narrative-depth
|
||||
- community-owned-ip-theory-preserves-concentrated-creative-execution-through-strategic-operational-separation
|
||||
reweave_edges:
|
||||
- Community-owned IP theory preserves concentrated creative execution by separating strategic funding decisions from operational creative development|related|2026-04-17
|
||||
- pudgy-penguins-inverts-web3-ip-strategy-by-prioritizing-mainstream-distribution-before-community-building|related|2026-04-17
|
||||
- Negative CAC model inverts IP economics by treating merchandise as profitable user acquisition rather than monetization endpoint|related|2026-04-24
|
||||
sourced_from: ["inbox/archive/entertainment/2026-04-xx-coindesk-pudgy-penguins-blueprint-tokenized-culture.md", "inbox/archive/entertainment/2026-03-10-coindesk-pudgy-world-launch-club-penguin-moment.md"]
|
||||
supports:
|
||||
- Community-owned IP demonstrates financial evangelism alignment (holders evangelize because tokens appreciate) but not narrative governance alignment (holders don't control creative or commercial decisions)
|
||||
- Financial alignment without governance rights is sufficient to drive brand growth at scale, making governance mechanisms non-necessary for commercial outcomes
|
||||
---
|
||||
|
||||
# Community-owned IP is community-branded but not community-governed in flagship Web3 projects
|
||||
|
|
@ -37,4 +51,4 @@ The Mediawan co-production structure preserves concentrated creative control whi
|
|||
|
||||
**Source:** SEC EDGAR Canary Capital PENGU ETF S-1, March 2025
|
||||
|
||||
SEC filing for Canary Capital PENGU ETF provides legal disclosure that token holders have 'no direct claim on brand revenues, no staking yields, and no governance over meaningful cash flows' and only receive 'closer association with members of the Pudgy Penguins community.' All major commercial decisions (Walmart expansion, Visa card, partnerships, IPO planning) made by CEO Luca Netz without documented community vote.
|
||||
SEC filing for Canary Capital PENGU ETF provides legal disclosure that token holders have 'no direct claim on brand revenues, no staking yields, and no governance over meaningful cash flows' and only receive 'closer association with members of the Pudgy Penguins community.' All major commercial decisions (Walmart expansion, Visa card, partnerships, IPO planning) made by CEO Luca Netz without documented community vote.
|
||||
|
|
@ -13,12 +13,14 @@ related:
|
|||
- Creator IP that persists independent of the creator's personal brand is the emerging structural advantage in the creator economy because it enables revenue streams that survive beyond individual creator burnout or platform shifts
|
||||
- Creator platform competition is converging on all-in-one owned distribution infrastructure where newsletter, podcast, and subscription bundling becomes the default business model
|
||||
- Hollywood studios now negotiate deals on creator terms rather than studio terms because creators control distribution access and audience relationships that studios need
|
||||
- Talent-driven creator brands concentrate all brand equity in a single person, creating reputational vulnerability that directly threatens scarce complement revenue streams
|
||||
reweave_edges:
|
||||
- creators-became-primary-distribution-layer-for-under-35-news-consumption-by-2025-surpassing-traditional-channels|related|2026-04-04
|
||||
- unnatural-brand-creator-narratives-damage-audience-trust-by-signaling-commercial-capture-rather-than-genuine-creative-collaboration|related|2026-04-04
|
||||
- Creator IP that persists independent of the creator's personal brand is the emerging structural advantage in the creator economy because it enables revenue streams that survive beyond individual creator burnout or platform shifts|related|2026-04-17
|
||||
- Creator platform competition is converging on all-in-one owned distribution infrastructure where newsletter, podcast, and subscription bundling becomes the default business model|related|2026-04-17
|
||||
- Hollywood studios now negotiate deals on creator terms rather than studio terms because creators control distribution access and audience relationships that studios need|related|2026-04-17
|
||||
- Talent-driven creator brands concentrate all brand equity in a single person, creating reputational vulnerability that directly threatens scarce complement revenue streams|related|2026-05-07
|
||||
sourced_from:
|
||||
- inbox/archive/entertainment/2025-12-16-exchangewire-creator-economy-2026-community-credibility.md
|
||||
---
|
||||
|
|
|
|||
|
|
@ -10,10 +10,18 @@ agent: clay
|
|||
sourced_from: entertainment/2026-05-06-pengu-sec-filing-no-governance-ownership-vs-evangelism.md
|
||||
scope: causal
|
||||
sourcer: SEC EDGAR / Canary Capital
|
||||
challenges: ["community ownership accelerates growth through aligned evangelism not passive holding"]
|
||||
related: ["community ownership accelerates growth through aligned evangelism not passive holding", "nft-holder-ip-licensing-converts-speculation-to-evangelism-through-revenue-sharing", "negative-cac-model-inverts-ip-economics-by-treating-merchandise-as-profitable-user-acquisition"]
|
||||
challenges:
|
||||
- community ownership accelerates growth through aligned evangelism not passive holding
|
||||
related:
|
||||
- community ownership accelerates growth through aligned evangelism not passive holding
|
||||
- nft-holder-ip-licensing-converts-speculation-to-evangelism-through-revenue-sharing
|
||||
- negative-cac-model-inverts-ip-economics-by-treating-merchandise-as-profitable-user-acquisition
|
||||
supports:
|
||||
- Community-owned IP demonstrates financial evangelism alignment (holders evangelize because tokens appreciate) but not narrative governance alignment (holders don't control creative or commercial decisions)
|
||||
reweave_edges:
|
||||
- Community-owned IP demonstrates financial evangelism alignment (holders evangelize because tokens appreciate) but not narrative governance alignment (holders don't control creative or commercial decisions)|supports|2026-05-07
|
||||
---
|
||||
|
||||
# Financial alignment without governance rights is sufficient to drive brand growth at scale, making governance mechanisms non-necessary for commercial outcomes
|
||||
|
||||
Pudgy Penguins demonstrates that financial alignment alone—without governance rights—can drive brand growth at enterprise scale. Despite SEC filing disclosure that PENGU token holders have 'no direct claim on brand revenues' and 'no governance over meaningful cash flows,' the brand achieved 2M+ units sold across 3,100 Walmart stores, partnerships with Visa, Manchester City, NHL, and NASCAR, and is targeting $120M in 2026 revenue (2x+ earlier projections) with 2027 IPO planning. The mechanism is financial evangelism: holders promote the brand because their tokens/NFTs appreciate with brand success, not because they control creative or commercial decisions. This challenges the stronger form of community ownership thesis that governance participation is necessary for commercial scale. The evidence suggests governance is a sufficient condition for community-driven growth but not a necessary one—financial alignment through token appreciation creates adequate incentive for evangelism without requiring decision-making authority. The Pudgy Penguins model is more accurately described as 'community financial association' rather than 'community governance,' yet it achieves comparable commercial outcomes to governance-enabled models.
|
||||
Pudgy Penguins demonstrates that financial alignment alone—without governance rights—can drive brand growth at enterprise scale. Despite SEC filing disclosure that PENGU token holders have 'no direct claim on brand revenues' and 'no governance over meaningful cash flows,' the brand achieved 2M+ units sold across 3,100 Walmart stores, partnerships with Visa, Manchester City, NHL, and NASCAR, and is targeting $120M in 2026 revenue (2x+ earlier projections) with 2027 IPO planning. The mechanism is financial evangelism: holders promote the brand because their tokens/NFTs appreciate with brand success, not because they control creative or commercial decisions. This challenges the stronger form of community ownership thesis that governance participation is necessary for commercial scale. The evidence suggests governance is a sufficient condition for community-driven growth but not a necessary one—financial alignment through token appreciation creates adequate incentive for evangelism without requiring decision-making authority. The Pudgy Penguins model is more accurately described as 'community financial association' rather than 'community governance,' yet it achieves comparable commercial outcomes to governance-enabled models.
|
||||
|
|
@ -10,7 +10,21 @@ agent: vida
|
|||
sourced_from: health/2026-osmind-glp1-psychiatric-drugs-tonic-phasic.md
|
||||
scope: causal
|
||||
sourcer: Osmind
|
||||
related: ["glp1-anhedonia-undermines-social-engagement-as-non-clinical-health-determinant", "food-noise-quiet-narrative-reframes-glp1-anhedonia-as-liberation", "glp1-receptor-agonists-address-substance-use-disorders-through-mesolimbic-dopamine-modulation", "semaglutide-produces-large-effect-aud-reduction-through-vta-dopamine-suppression", "hedonic-eating-dopamine-circuit-adapts-to-glp1-suppression-explaining-continuous-delivery-requirement", "glp-1-receptor-agonists-require-continuous-treatment-because-metabolic-benefits-reverse-within-28-52-weeks-of-discontinuation", "glp1-receptor-agonists-provide-cardiovascular-benefits-through-weight-independent-mechanisms", "glp1-anhedonia-tonic-receptor-occupancy-dose-dependent-reversible"]
|
||||
related:
|
||||
- glp1-anhedonia-undermines-social-engagement-as-non-clinical-health-determinant
|
||||
- food-noise-quiet-narrative-reframes-glp1-anhedonia-as-liberation
|
||||
- glp1-receptor-agonists-address-substance-use-disorders-through-mesolimbic-dopamine-modulation
|
||||
- semaglutide-produces-large-effect-aud-reduction-through-vta-dopamine-suppression
|
||||
- hedonic-eating-dopamine-circuit-adapts-to-glp1-suppression-explaining-continuous-delivery-requirement
|
||||
- glp-1-receptor-agonists-require-continuous-treatment-because-metabolic-benefits-reverse-within-28-52-weeks-of-discontinuation
|
||||
- glp1-receptor-agonists-provide-cardiovascular-benefits-through-weight-independent-mechanisms
|
||||
- glp1-anhedonia-tonic-receptor-occupancy-dose-dependent-reversible
|
||||
supports:
|
||||
- Human dose-response data on GLP-1 psychiatric effects are absent from the literature despite mechanistic evidence that tonic receptor occupancy at therapeutic weight-loss doses suppresses dopamine signaling differently than lower psychiatric doses
|
||||
- GLP-1 clinical trials systematically lack validated hedonic measurement instruments making anhedonia invisible to regulatory infrastructure despite available tools like SHAPS
|
||||
reweave_edges:
|
||||
- Human dose-response data on GLP-1 psychiatric effects are absent from the literature despite mechanistic evidence that tonic receptor occupancy at therapeutic weight-loss doses suppresses dopamine signaling differently than lower psychiatric doses|supports|2026-05-07
|
||||
- GLP-1 clinical trials systematically lack validated hedonic measurement instruments making anhedonia invisible to regulatory infrastructure despite available tools like SHAPS|supports|2026-05-07
|
||||
---
|
||||
|
||||
# GLP-1-induced anhedonia is a tonic receptor occupancy phenomenon, not an inherent pharmacological property, resolving with dose reduction because natural GLP-1 is phasic
|
||||
|
|
@ -22,4 +36,4 @@ Natural GLP-1 is phasic: it spikes after meals and degrades within 1-2 minutes d
|
|||
|
||||
**Source:** Sa et al., Diabetes Obesity and Metabolism 2026
|
||||
|
||||
Systematic review of 80 RCTs (107,860 participants) finds 'direct evidence linking GLP-1RAs to anhedonia' is 'sparse' and 'most hypotheses about CNS involvement remain speculative due to lack of integrated neurobiological or mechanistic studies.' No reversibility data included in review. Preclinical evidence shows dose-dependent effects, but human dose-response data are completely absent.
|
||||
Systematic review of 80 RCTs (107,860 participants) finds 'direct evidence linking GLP-1RAs to anhedonia' is 'sparse' and 'most hypotheses about CNS involvement remain speculative due to lack of integrated neurobiological or mechanistic studies.' No reversibility data included in review. Preclinical evidence shows dose-dependent effects, but human dose-response data are completely absent.
|
||||
|
|
@ -22,8 +22,10 @@ related:
|
|||
- glp1-prescribing-competency-gap-primary-care-psychiatric-monitoring
|
||||
supports:
|
||||
- Cultural narrative framing 'food noise quiet' as liberation delays recognition of GLP-1 dopamine suppression harm
|
||||
- GLP-1 clinical trials systematically lack validated hedonic measurement instruments making anhedonia invisible to regulatory infrastructure despite available tools like SHAPS
|
||||
reweave_edges:
|
||||
- Cultural narrative framing 'food noise quiet' as liberation delays recognition of GLP-1 dopamine suppression harm|supports|2026-05-06
|
||||
- GLP-1 clinical trials systematically lack validated hedonic measurement instruments making anhedonia invisible to regulatory infrastructure despite available tools like SHAPS|supports|2026-05-07
|
||||
---
|
||||
|
||||
# GLP-1 anhedonia mechanism undermines social engagement and meaning as non-clinical health determinants even while treating metabolic disease
|
||||
|
|
|
|||
|
|
@ -12,12 +12,15 @@ scope: structural
|
|||
sourcer: "NPR (@NPRHealth)"
|
||||
supports:
|
||||
- glp1-eating-disorder-risk-subtype-specific-protective-bed-harmful-restrictive
|
||||
- GLP-1 adolescent prescribing requires eating disorder screening because subclinical restrictive behaviors are clinically invisible without structured assessment
|
||||
related:
|
||||
- glp1-eating-disorder-screening-gap-structural-capacity-not-clinical-knowledge
|
||||
- glp1-eating-disorder-screening-lacks-reimbursement-infrastructure-despite-identified-risk-population
|
||||
- glp1-prescribing-competency-gap-primary-care-psychiatric-monitoring
|
||||
reweave_edges:
|
||||
- GLP-1 adolescent prescribing requires eating disorder screening because subclinical restrictive behaviors are clinically invisible without structured assessment|supports|2026-05-07
|
||||
---
|
||||
|
||||
# GLP-1 prescribing creates systematic screening gap for atypical anorexia because normal BMI masks active restrictive psychopathology
|
||||
|
||||
Dr. Kim Dennis identifies atypical anorexia as a specific high-risk population for GLP-1 harm that standard screening protocols fail to detect. Atypical anorexia nervosa is characterized by meeting full diagnostic criteria for anorexia nervosa—including restrictive eating patterns, fear of weight gain, and body image disturbance—while maintaining a BMI in the normal or overweight range. This creates a dangerous screening gap: these patients appear as textbook GLP-1 candidates based on BMI criteria alone, but have active eating disorder psychopathology that GLP-1's appetite suppression will exacerbate. The article notes that 'nearly a tenth of people will meet the clinical benchmarks of an eating disorder at some point in their lives,' creating substantial overlap with the obesity treatment population. Dr. Samantha DeCaro emphasizes that eating disorders involve 'emotional, relational, and biological drivers' that weight loss alone does not address. The structural problem is that BMI-based eligibility screening—the primary gate for GLP-1 access—is precisely the metric that makes atypical anorexia invisible. This is distinct from general eating disorder risk: it's a population-specific screening failure where the diagnostic tool (BMI) actively obscures the contraindication.
|
||||
Dr. Kim Dennis identifies atypical anorexia as a specific high-risk population for GLP-1 harm that standard screening protocols fail to detect. Atypical anorexia nervosa is characterized by meeting full diagnostic criteria for anorexia nervosa—including restrictive eating patterns, fear of weight gain, and body image disturbance—while maintaining a BMI in the normal or overweight range. This creates a dangerous screening gap: these patients appear as textbook GLP-1 candidates based on BMI criteria alone, but have active eating disorder psychopathology that GLP-1's appetite suppression will exacerbate. The article notes that 'nearly a tenth of people will meet the clinical benchmarks of an eating disorder at some point in their lives,' creating substantial overlap with the obesity treatment population. Dr. Samantha DeCaro emphasizes that eating disorders involve 'emotional, relational, and biological drivers' that weight loss alone does not address. The structural problem is that BMI-based eligibility screening—the primary gate for GLP-1 access—is precisely the metric that makes atypical anorexia invisible. This is distinct from general eating disorder risk: it's a population-specific screening failure where the diagnostic tool (BMI) actively obscures the contraindication.
|
||||
|
|
@ -10,7 +10,23 @@ agent: vida
|
|||
sourced_from: health/2026-osmind-glp1-psychiatric-drugs-tonic-phasic.md
|
||||
scope: structural
|
||||
sourcer: Osmind
|
||||
related: ["glp1-therapy-requires-nutritional-monitoring-infrastructure-but-92-percent-receive-no-dietitian-support", "healthcare AI creates a Jevons paradox because adding capacity to sick care induces more demand for sick care", "glp1-discontinuation-predicted-by-psychiatric-comorbidity-creating-access-adherence-trap", "glp1-eating-disorder-screening-gap-structural-capacity-not-clinical-knowledge", "glp1-psychiatric-effects-directionally-opposite-metabolic-versus-psychiatric-populations", "glp1-anhedonia-undermines-social-engagement-as-non-clinical-health-determinant", "glp1-atypical-anorexia-screening-gap-creates-invisible-high-risk-population", "glp1-harm-mediated-by-cultural-weight-stigma-not-pharmacology-alone", "glp1-prescribing-competency-gap-primary-care-psychiatric-monitoring", "glp1-anhedonia-tonic-receptor-occupancy-dose-dependent-reversible"]
|
||||
related:
|
||||
- glp1-therapy-requires-nutritional-monitoring-infrastructure-but-92-percent-receive-no-dietitian-support
|
||||
- healthcare AI creates a Jevons paradox because adding capacity to sick care induces more demand for sick care
|
||||
- glp1-discontinuation-predicted-by-psychiatric-comorbidity-creating-access-adherence-trap
|
||||
- glp1-eating-disorder-screening-gap-structural-capacity-not-clinical-knowledge
|
||||
- glp1-psychiatric-effects-directionally-opposite-metabolic-versus-psychiatric-populations
|
||||
- glp1-anhedonia-undermines-social-engagement-as-non-clinical-health-determinant
|
||||
- glp1-atypical-anorexia-screening-gap-creates-invisible-high-risk-population
|
||||
- glp1-harm-mediated-by-cultural-weight-stigma-not-pharmacology-alone
|
||||
- glp1-prescribing-competency-gap-primary-care-psychiatric-monitoring
|
||||
- glp1-anhedonia-tonic-receptor-occupancy-dose-dependent-reversible
|
||||
supports:
|
||||
- Human dose-response data on GLP-1 psychiatric effects are absent from the literature despite mechanistic evidence that tonic receptor occupancy at therapeutic weight-loss doses suppresses dopamine signaling differently than lower psychiatric doses
|
||||
- GLP-1 clinical trials systematically lack validated hedonic measurement instruments making anhedonia invisible to regulatory infrastructure despite available tools like SHAPS
|
||||
reweave_edges:
|
||||
- Human dose-response data on GLP-1 psychiatric effects are absent from the literature despite mechanistic evidence that tonic receptor occupancy at therapeutic weight-loss doses suppresses dopamine signaling differently than lower psychiatric doses|supports|2026-05-07
|
||||
- GLP-1 clinical trials systematically lack validated hedonic measurement instruments making anhedonia invisible to regulatory infrastructure despite available tools like SHAPS|supports|2026-05-07
|
||||
---
|
||||
|
||||
# Primary care prescribers of GLP-1s at therapeutic weight-loss doses lack psychiatric competency to monitor for CNS effects, creating structural risk of anhedonia in patients without psychiatric support
|
||||
|
|
@ -22,4 +38,4 @@ GLP-1 receptors are densely distributed in VTA, nucleus accumbens, insula, and p
|
|||
|
||||
**Source:** Psychopharmacology Institute Q1 2026 Review
|
||||
|
||||
The Psychopharmacology Institute — a CME platform for practicing psychiatrists — now covers GLP-1 receptor agonists as emerging psychiatric pharmacology in quarterly clinical reviews. This signals that professional psychiatric education is actively incorporating GLP-1 into the psychiatric medication framework, moving beyond endocrinology-only prescribing. However, the review does not provide clinical screening protocols for psychiatrists evaluating patients already prescribed GLP-1s by other providers, indicating the competency gap persists at the protocol level despite conceptual recognition.
|
||||
The Psychopharmacology Institute — a CME platform for practicing psychiatrists — now covers GLP-1 receptor agonists as emerging psychiatric pharmacology in quarterly clinical reviews. This signals that professional psychiatric education is actively incorporating GLP-1 into the psychiatric medication framework, moving beyond endocrinology-only prescribing. However, the review does not provide clinical screening protocols for psychiatrists evaluating patients already prescribed GLP-1s by other providers, indicating the competency gap persists at the protocol level despite conceptual recognition.
|
||||
|
|
@ -19,11 +19,15 @@ related:
|
|||
- glp1-eating-disorder-risk-subtype-specific-protective-bed-harmful-restrictive
|
||||
- GLP-1 eating disorder risk doubles with prior mental health history creating identifiable high-risk population
|
||||
- glp1-prescribing-competency-gap-primary-care-psychiatric-monitoring
|
||||
- Human dose-response data on GLP-1 psychiatric effects are absent from the literature despite mechanistic evidence that tonic receptor occupancy at therapeutic weight-loss doses suppresses dopamine signaling differently than lower psychiatric doses
|
||||
- Within-individual study designs resolve GLP-1 psychiatric safety divergence by eliminating confounding by indication that creates spurious risk signals in matched cohort studies
|
||||
supports:
|
||||
- WHO December 2025 GLP-1 obesity guideline contains no eating disorder screening requirement despite pharmacovigilance signal predating guideline by 18+ months
|
||||
reweave_edges:
|
||||
- WHO December 2025 GLP-1 obesity guideline contains no eating disorder screening requirement despite pharmacovigilance signal predating guideline by 18+ months|supports|2026-05-05
|
||||
- GLP-1 eating disorder risk doubles with prior mental health history creating identifiable high-risk population|related|2026-05-06
|
||||
- Human dose-response data on GLP-1 psychiatric effects are absent from the literature despite mechanistic evidence that tonic receptor occupancy at therapeutic weight-loss doses suppresses dopamine signaling differently than lower psychiatric doses|related|2026-05-07
|
||||
- Within-individual study designs resolve GLP-1 psychiatric safety divergence by eliminating confounding by indication that creates spurious risk signals in matched cohort studies|related|2026-05-07
|
||||
---
|
||||
|
||||
# GLP-1 psychiatric effects are directionally opposite in metabolic versus psychiatric disease patients — protective in metabolic cohorts but potentially harmful in severe psychiatric comorbidity with concurrent psychotropic use
|
||||
|
|
|
|||
|
|
@ -13,6 +13,7 @@ sourcer: Hendershot CS et al.
|
|||
supports:
|
||||
- glp1-receptor-agonists-address-substance-use-disorders-through-mesolimbic-dopamine-modulation
|
||||
- behavioral-biological-health-dichotomy-false-for-reward-dysregulation-conditions
|
||||
- Semaglutide reduces worsening of depression, anxiety, and substance use disorder by 40-50% in people with pre-existing mental illness through within-individual comparison
|
||||
related:
|
||||
- hedonic-eating-dopamine-circuit-adapts-to-glp1-suppression-explaining-continuous-delivery-requirement
|
||||
- glp1-receptor-agonists-address-substance-use-disorders-through-mesolimbic-dopamine-modulation
|
||||
|
|
@ -21,6 +22,8 @@ related:
|
|||
- semaglutide-produces-large-effect-aud-reduction-through-vta-dopamine-suppression
|
||||
- glp1-receptor-agonists-demonstrate-superior-efficacy-for-alcohol-use-disorder-in-comorbid-obesity-population
|
||||
- glp1-anhedonia-tonic-receptor-occupancy-dose-dependent-reversible
|
||||
reweave_edges:
|
||||
- Semaglutide reduces worsening of depression, anxiety, and substance use disorder by 40-50% in people with pre-existing mental illness through within-individual comparison|supports|2026-05-07
|
||||
---
|
||||
|
||||
# Semaglutide produces large-effect-size reductions in alcohol consumption and craving through VTA dopamine reward circuit suppression
|
||||
|
|
@ -60,4 +63,4 @@ Dr Marie Spreckley highlighted critical confound: 'All participants received CBT
|
|||
|
||||
**Source:** eClinicalMedicine meta-analysis, 2025
|
||||
|
||||
Semaglutide showed most consistent effects across 14 studies in meta-analysis of 5.26M patients. AUDIT score reduction of 7.81 points and 28% lower AUD diagnosis risk (HR 0.72) in real-world metabolic patient population, separate from treatment-seeking context.
|
||||
Semaglutide showed most consistent effects across 14 studies in meta-analysis of 5.26M patients. AUDIT score reduction of 7.81 points and 28% lower AUD diagnosis risk (HR 0.72) in real-world metabolic patient population, separate from treatment-seeking context.
|
||||
|
|
@ -10,9 +10,19 @@ agent: vida
|
|||
sourced_from: health/2026-03-lancetpsychiatry-glp1-mental-illness-swedish-cohort.md
|
||||
scope: structural
|
||||
sourcer: Lancet Psychiatry / Karolinska Institutet
|
||||
related: ["glp1-discontinuation-predicted-by-psychiatric-comorbidity-creating-access-adherence-trap", "glp1-eating-disorder-causality-expert-divergence-reflects-evidence-gap", "glp1-psychiatric-effects-directionally-opposite-metabolic-versus-psychiatric-populations", "semaglutide-reduces-depression-worsening-44-percent-in-diagnosed-patients-through-glp1r-psychiatric-mechanism", "glp1-eating-disorder-risk-doubles-with-prior-mental-health-history", "glp1-eating-disorder-pharmacovigilance-signal-class-effect-obesity-population-specific"]
|
||||
related:
|
||||
- glp1-discontinuation-predicted-by-psychiatric-comorbidity-creating-access-adherence-trap
|
||||
- glp1-eating-disorder-causality-expert-divergence-reflects-evidence-gap
|
||||
- glp1-psychiatric-effects-directionally-opposite-metabolic-versus-psychiatric-populations
|
||||
- semaglutide-reduces-depression-worsening-44-percent-in-diagnosed-patients-through-glp1r-psychiatric-mechanism
|
||||
- glp1-eating-disorder-risk-doubles-with-prior-mental-health-history
|
||||
- glp1-eating-disorder-pharmacovigilance-signal-class-effect-obesity-population-specific
|
||||
supports:
|
||||
- Semaglutide reduces worsening of depression, anxiety, and substance use disorder by 40-50% in people with pre-existing mental illness through within-individual comparison
|
||||
reweave_edges:
|
||||
- Semaglutide reduces worsening of depression, anxiety, and substance use disorder by 40-50% in people with pre-existing mental illness through within-individual comparison|supports|2026-05-07
|
||||
---
|
||||
|
||||
# Within-individual study designs resolve GLP-1 psychiatric safety divergence by eliminating confounding by indication that creates spurious risk signals in matched cohort studies
|
||||
|
||||
The apparent divergence in GLP-1 psychiatric safety evidence—matched cohort studies showing 195% increased MDD risk versus RCTs and within-individual studies showing protective or neutral effects—is resolved by understanding confounding by indication. The Swedish Lancet Psychiatry study (March 2026) used within-individual stratified Cox models comparing the same person's psychiatric outcomes during periods ON versus OFF semaglutide. This design eliminates all time-invariant confounding including baseline psychiatric severity, unmeasured comorbidities, and social circumstances that propensity score matching cannot fully capture. The finding of 42% reduced psychiatric worsening during semaglutide use periods directly contradicts the matched cohort signal and demonstrates that the 195% MDD risk increase reflects selection bias: people prescribed GLP-1s for obesity have systematically worse baseline mental health than matched controls, even after propensity score adjustment. The FDA meta-analysis of 91 placebo-controlled RCTs (107,910 patients) showing no increased psychiatric risk converges with the within-individual finding, while matched cohort studies diverge due to residual confounding. This establishes a methodological hierarchy: within-individual designs and RCTs should dominate inference over matched cohort studies when confounding by indication is structurally present. The resolution has major implications for GLP-1 prescribing guidelines and psychiatric screening protocols.
|
||||
The apparent divergence in GLP-1 psychiatric safety evidence—matched cohort studies showing 195% increased MDD risk versus RCTs and within-individual studies showing protective or neutral effects—is resolved by understanding confounding by indication. The Swedish Lancet Psychiatry study (March 2026) used within-individual stratified Cox models comparing the same person's psychiatric outcomes during periods ON versus OFF semaglutide. This design eliminates all time-invariant confounding including baseline psychiatric severity, unmeasured comorbidities, and social circumstances that propensity score matching cannot fully capture. The finding of 42% reduced psychiatric worsening during semaglutide use periods directly contradicts the matched cohort signal and demonstrates that the 195% MDD risk increase reflects selection bias: people prescribed GLP-1s for obesity have systematically worse baseline mental health than matched controls, even after propensity score adjustment. The FDA meta-analysis of 91 placebo-controlled RCTs (107,910 patients) showing no increased psychiatric risk converges with the within-individual finding, while matched cohort studies diverge due to residual confounding. This establishes a methodological hierarchy: within-individual designs and RCTs should dominate inference over matched cohort studies when confounding by indication is structurally present. The resolution has major implications for GLP-1 prescribing guidelines and psychiatric screening protocols.
|
||||
|
|
@ -16,8 +16,10 @@ related:
|
|||
- futarchy-governance-markets-create-insider-trading-paradox-because-informed-governance-participants-are-simultaneously-the-most-valuable-traders-and-the-most-restricted-under-insider-trading-frameworks
|
||||
reweave_edges:
|
||||
- Democratic demand for CFTC enforcement of existing war-bet rules creates a regulatory dilemma where enforcing expands offshore jurisdiction while refusing creates political ammunition|related|2026-04-18
|
||||
- The Prediction Market Act of 2026's insider trading prohibitions for government officials signal that prediction market regulation treats informed participation as securities-like rather than gambling-like|supports|2026-05-07
|
||||
supports:
|
||||
- Prediction market insider trading concentrates in three principal types — government officials with policy information, ICO teams with operational information, and candidates with electoral information — each requiring different enforcement mechanisms
|
||||
- The Prediction Market Act of 2026's insider trading prohibitions for government officials signal that prediction market regulation treats informed participation as securities-like rather than gambling-like
|
||||
---
|
||||
|
||||
# Congressional insider trading legislation for prediction markets treats them as financial instruments not gambling strengthening DCM regulatory legitimacy
|
||||
|
|
@ -34,4 +36,4 @@ The ANPRM includes 'How to handle inside information in prediction markets?' as
|
|||
|
||||
**Source:** Congressional action timeline, March-April 2026
|
||||
|
||||
Senate unanimously passed ban on senators/staff betting on prediction markets (2026). Democrats urged CFTC (April 30) to strengthen enforcement against sports prediction market insider trading. This legislative activity treats prediction markets as financial instruments requiring insider trading controls, not gambling requiring prohibition.
|
||||
Senate unanimously passed ban on senators/staff betting on prediction markets (2026). Democrats urged CFTC (April 30) to strengthen enforcement against sports prediction market insider trading. This legislative activity treats prediction markets as financial instruments requiring insider trading controls, not gambling requiring prohibition.
|
||||
|
|
@ -21,11 +21,13 @@ related:
|
|||
- state-prediction-market-enforcement-exclusively-targets-sports-centralized-platforms-seven-state-pattern
|
||||
- cftc-anprm-scope-excludes-governance-markets-through-dcm-external-event-framing
|
||||
- Third Circuit's expansive swap definition classifies sports event contracts as financial derivatives by interpreting commercial consequence to include any stakeholder financial impact
|
||||
- The Prediction Market Act of 2026's statutory event contract definition ('tied to the occurrence or non-occurrence of a future event') could sweep in futarchy governance markets by treating proposal outcomes as future events
|
||||
supports:
|
||||
- CFTC ANPRM scope excludes governance markets through DCM external-event framing creating regulatory gap for endogenous settlement mechanisms
|
||||
reweave_edges:
|
||||
- CFTC ANPRM scope excludes governance markets through DCM external-event framing creating regulatory gap for endogenous settlement mechanisms|supports|2026-04-30
|
||||
- Third Circuit's expansive swap definition classifies sports event contracts as financial derivatives by interpreting commercial consequence to include any stakeholder financial impact|related|2026-05-05
|
||||
- The Prediction Market Act of 2026's statutory event contract definition ('tied to the occurrence or non-occurrence of a future event') could sweep in futarchy governance markets by treating proposal outcomes as future events|related|2026-05-07
|
||||
---
|
||||
|
||||
# MetaDAO's TWAP settlement mechanism may exclude it from event contract definitions because it settles against endogenous token price rather than external real-world events
|
||||
|
|
@ -125,4 +127,4 @@ Cleary Gottlieb identifies a separate SEC jurisdictional track for company-speci
|
|||
|
||||
**Source:** McCormick-Gillibrand bill, April 30, 2026
|
||||
|
||||
The Prediction Market Act of 2026's statutory definition of event contracts as instruments 'tied to the occurrence or non-occurrence of a future event' creates a new test for the endogeneity argument. If a governance proposal vote is classified as a 'future event,' then TWAP settlement against conditional token prices may still fall within the statutory definition even if the settlement mechanism is endogenous. The bill's language shifts the analytical question from 'is the settlement mechanism endogenous?' to 'is the underlying trigger a future event?'
|
||||
The Prediction Market Act of 2026's statutory definition of event contracts as instruments 'tied to the occurrence or non-occurrence of a future event' creates a new test for the endogeneity argument. If a governance proposal vote is classified as a 'future event,' then TWAP settlement against conditional token prices may still fall within the statutory definition even if the settlement mechanism is endogenous. The bill's language shifts the analytical question from 'is the settlement mechanism endogenous?' to 'is the underlying trigger a future event?'
|
||||
|
|
@ -14,10 +14,12 @@ related:
|
|||
- cftc-anprm-insider-trading-framework-gap-creates-futarchy-governance-paradox
|
||||
- insider-trading-in-futarchy-improves-governance-by-accelerating-ground-truth-incorporation-into-conditional-markets
|
||||
- congressional-insider-trading-legislation-for-prediction-markets-treats-them-as-financial-instruments-not-gambling-strengthening-dcm-regulatory-legitimacy
|
||||
- The Prediction Market Act of 2026's insider trading prohibitions for government officials signal that prediction market regulation treats informed participation as securities-like rather than gambling-like
|
||||
supports:
|
||||
- Adversarial self-testing creates a novel threat model for prediction market platforms through deliberate rule violations as PR strategy
|
||||
reweave_edges:
|
||||
- Adversarial self-testing creates a novel threat model for prediction market platforms through deliberate rule violations as PR strategy|supports|2026-04-24
|
||||
- The Prediction Market Act of 2026's insider trading prohibitions for government officials signal that prediction market regulation treats informed participation as securities-like rather than gambling-like|related|2026-05-07
|
||||
---
|
||||
|
||||
# Prediction market insider trading concentrates in three principal types — government officials with policy information, ICO teams with operational information, and candidates with electoral information — each requiring different enforcement mechanisms
|
||||
|
|
|
|||
|
|
@ -10,9 +10,20 @@ agent: astra
|
|||
sourced_from: space-development/2026-04-xx-china-in-space-three-body-vs-orbital-chenguang.md
|
||||
scope: structural
|
||||
sourcer: china-in-space.com
|
||||
related: ["vertical-integration-bypasses-demand-threshold-through-captive-internal-demand", "china-parallel-odc-programs-create-asymmetric-state-backing-advantage", "China is the only credible peer competitor in space with comprehensive capabilities and state-directed acceleration closing the reusability gap in 5-8 years", "china-star-compute-bri-orbital-infrastructure-creates-geopolitical-technology-lock-in", "orbital-data-centers-activate-bottom-up-from-small-satellite-proof-of-concept-with-tier-specific-launch-cost-gates"]
|
||||
related:
|
||||
- vertical-integration-bypasses-demand-threshold-through-captive-internal-demand
|
||||
- china-parallel-odc-programs-create-asymmetric-state-backing-advantage
|
||||
- China is the only credible peer competitor in space with comprehensive capabilities and state-directed acceleration closing the reusability gap in 5-8 years
|
||||
- china-star-compute-bri-orbital-infrastructure-creates-geopolitical-technology-lock-in
|
||||
- orbital-data-centers-activate-bottom-up-from-small-satellite-proof-of-concept-with-tier-specific-launch-cost-gates
|
||||
supports:
|
||||
- China's Orbital Chenguang financing through $8.4B state banking credit lines enables orbital infrastructure development without near-term commercial viability requirements, creating asymmetric capital advantage over equity-funded competitors
|
||||
- China's Three-Body Computing Constellation expansion explicitly targets Belt and Road Initiative regions as orbital AI processing service markets, embedding orbital computing into China's global infrastructure strategy
|
||||
reweave_edges:
|
||||
- China's Orbital Chenguang financing through $8.4B state banking credit lines enables orbital infrastructure development without near-term commercial viability requirements, creating asymmetric capital advantage over equity-funded competitors|supports|2026-05-07
|
||||
- China's Three-Body Computing Constellation expansion explicitly targets Belt and Road Initiative regions as orbital AI processing service markets, embedding orbital computing into China's global infrastructure strategy|supports|2026-05-07
|
||||
---
|
||||
|
||||
# China's orbital computing strategy involves at least two parallel programs at different maturity levels — Three-Body (operational civilian/commercial) and Orbital Chenguang (pre-operational state-backed) — following China's established dual-track approach to strategic technology development
|
||||
|
||||
Three-Body Computing Constellation (ADA Space + Zhejiang Lab) has been operational since May 2025 with 12 satellites launched, completing a 9-month in-orbit test by February 2026. The constellation delivers 744 TOPS per satellite, 5 PFLOPS collectively, with 94% classification accuracy without ground intervention. Meanwhile, Orbital Chenguang (Beijing Astro-future Institute) has not yet launched its first experimental satellite as of April 2026, despite securing $8.4B in credit lines from 12 major state banks. The maturity gap is minimum 3-5 years. This mirrors China's established pattern in commercial launch vehicles where Long March (state), Galactic Energy (commercial), and LandSpace (commercial) coexist with different mandates. Three-Body serves the science/commercial proof market now with university/commercial partnership funding; Orbital Chenguang will serve the state infrastructure market at gigawatt scale with state banking credit. The programs are complementary rather than competitive — China is hedging across multiple operators while running parallel tracks without forcing competition.
|
||||
Three-Body Computing Constellation (ADA Space + Zhejiang Lab) has been operational since May 2025 with 12 satellites launched, completing a 9-month in-orbit test by February 2026. The constellation delivers 744 TOPS per satellite, 5 PFLOPS collectively, with 94% classification accuracy without ground intervention. Meanwhile, Orbital Chenguang (Beijing Astro-future Institute) has not yet launched its first experimental satellite as of April 2026, despite securing $8.4B in credit lines from 12 major state banks. The maturity gap is minimum 3-5 years. This mirrors China's established pattern in commercial launch vehicles where Long March (state), Galactic Energy (commercial), and LandSpace (commercial) coexist with different mandates. Three-Body serves the science/commercial proof market now with university/commercial partnership funding; Orbital Chenguang will serve the state infrastructure market at gigawatt scale with state banking credit. The programs are complementary rather than competitive — China is hedging across multiple operators while running parallel tracks without forcing competition.
|
||||
|
|
@ -14,10 +14,16 @@ related:
|
|||
- military-commercial-space-architecture-convergence-creates-dual-use-orbital-infrastructure
|
||||
- china-is-the-only-credible-peer-competitor-in-space-with-comprehensive-capabilities-and-state-directed-acceleration-closing-the-reusability-gap-in-5-8-years
|
||||
- blue-origin-project-sunrise-signals-spacex-blue-origin-duopoly-in-orbital-compute-through-vertical-integration
|
||||
- China's Orbital Chenguang financing through $8.4B state banking credit lines enables orbital infrastructure development without near-term commercial viability requirements, creating asymmetric capital advantage over equity-funded competitors
|
||||
supports:
|
||||
- China's multiple parallel orbital data center programs with combined state backing exceeding projected US commercial ODC market creates asymmetric competitive advantage
|
||||
- China's orbital computing strategy involves at least two parallel programs at different maturity levels — Three-Body (operational civilian/commercial) and Orbital Chenguang (pre-operational state-backed) — following China's established dual-track approach to strategic technology development
|
||||
- China's Three-Body Computing Constellation expansion explicitly targets Belt and Road Initiative regions as orbital AI processing service markets, embedding orbital computing into China's global infrastructure strategy
|
||||
reweave_edges:
|
||||
- China's multiple parallel orbital data center programs with combined state backing exceeding projected US commercial ODC market creates asymmetric competitive advantage|supports|2026-04-26
|
||||
- China's orbital computing strategy involves at least two parallel programs at different maturity levels — Three-Body (operational civilian/commercial) and Orbital Chenguang (pre-operational state-backed) — following China's established dual-track approach to strategic technology development|supports|2026-05-07
|
||||
- China's Orbital Chenguang financing through $8.4B state banking credit lines enables orbital infrastructure development without near-term commercial viability requirements, creating asymmetric capital advantage over equity-funded competitors|related|2026-05-07
|
||||
- China's Three-Body Computing Constellation expansion explicitly targets Belt and Road Initiative regions as orbital AI processing service markets, embedding orbital computing into China's global infrastructure strategy|supports|2026-05-07
|
||||
---
|
||||
|
||||
# China's Star-Compute orbital computing program serves dual commercial and geopolitical functions by providing AI processing to Belt and Road Initiative partner nations to reduce Western technology dependency and create orbital infrastructure lock-in
|
||||
|
|
|
|||
|
|
@ -10,9 +10,13 @@ depends_on:
|
|||
- LEO satellite internet is the defining battleground of the space economy with Starlink 5 years ahead and only 3-4 mega-constellations viable
|
||||
supports:
|
||||
- A 1 million satellite orbital data center constellation at 500-2000km altitude represents the most extreme test of orbital debris governance yet proposed by adding collision risk that exceeds the entire current tracked debris population by 40x
|
||||
- Active satellite density in the 500-600km LEO band reached parity with debris density in 2025, crossing a threshold where collision hazard is jointly driven by operational satellites and existing debris
|
||||
- ESA's 2025 Space Environment Report concluded that passive mitigation is no longer sufficient and active debris removal is required, marking the first official acknowledgment that LEO has exceeded self-cleaning threshold
|
||||
reweave_edges:
|
||||
- A 1 million satellite orbital data center constellation at 500-2000km altitude represents the most extreme test of orbital debris governance yet proposed by adding collision risk that exceeds the entire current tracked debris population by 40x|supports|2026-05-05
|
||||
- FCC Chair Carr's rebuke of Amazon's orbital debris objections applies competitive market logic to a commons governance problem, treating Kessler Syndrome risk as a competitive standing question rather than a planetary externality|related|2026-05-06
|
||||
- Active satellite density in the 500-600km LEO band reached parity with debris density in 2025, crossing a threshold where collision hazard is jointly driven by operational satellites and existing debris|supports|2026-05-07
|
||||
- ESA's 2025 Space Environment Report concluded that passive mitigation is no longer sufficient and active debris removal is required, marking the first official acknowledgment that LEO has exceeded self-cleaning threshold|supports|2026-05-07
|
||||
related:
|
||||
- FCC Chair Carr's rebuke of Amazon's orbital debris objections applies competitive market logic to a commons governance problem, treating Kessler Syndrome risk as a competitive standing question rather than a planetary externality
|
||||
---
|
||||
|
|
|
|||
|
|
@ -6,8 +6,12 @@ confidence: likely
|
|||
source: "Astra, web research compilation February 2026"
|
||||
created: 2026-02-17
|
||||
depends_on:
|
||||
- "space governance gaps are widening not narrowing because technology advances exponentially while institutional design advances linearly"
|
||||
- "orbital debris is a classic commons tragedy where individual launch incentives are private but collision risk is externalized to all operators"
|
||||
- space governance gaps are widening not narrowing because technology advances exponentially while institutional design advances linearly
|
||||
- orbital debris is a classic commons tragedy where individual launch incentives are private but collision risk is externalized to all operators
|
||||
supports:
|
||||
- The CRASH clock fell from 121 days in 2018 to 2.8 days in 2025 as mega-constellations deployed, quantifying the compression of the governance window before cascade initiation becomes likely
|
||||
reweave_edges:
|
||||
- The CRASH clock fell from 121 days in 2018 to 2.8 days in 2025 as mega-constellations deployed, quantifying the compression of the governance window before cascade initiation becomes likely|supports|2026-05-07
|
||||
---
|
||||
|
||||
# Space traffic management is the most urgent governance gap because no authority has binding power to coordinate collision avoidance among thousands of operators
|
||||
|
|
@ -34,4 +38,4 @@ Relevant Notes:
|
|||
- [[orbital debris is a classic commons tragedy where individual launch incentives are private but collision risk is externalized to all operators]] — STM failure accelerates debris accumulation
|
||||
|
||||
Topics:
|
||||
- [[space exploration and development]]
|
||||
- [[space exploration and development]]
|
||||
|
|
@ -18,6 +18,10 @@ key_metrics:
|
|||
retail_locations: "30,000+"
|
||||
tracked_by: clay
|
||||
created: 2026-03-11
|
||||
supports:
|
||||
- Talent-driven creator brands concentrate all brand equity in a single person, creating reputational vulnerability that directly threatens scarce complement revenue streams
|
||||
reweave_edges:
|
||||
- Talent-driven creator brands concentrate all brand equity in a single person, creating reputational vulnerability that directly threatens scarce complement revenue streams|supports|2026-05-07
|
||||
---
|
||||
|
||||
# Beast Industries
|
||||
|
|
@ -30,4 +34,4 @@ Beast Industries is MrBeast's (Jimmy Donaldson) integrated media and consumer pr
|
|||
- **2025** — Feastables distributed through 30,000+ retail locations (Walmart, Target, 7-Eleven)
|
||||
|
||||
## Relationship to KB
|
||||
Beast Industries provides enterprise-scale validation of [[the media attractor state is community-filtered IP with AI-collapsed production costs where content becomes a loss leader for the scarce complements of fandom community and ownership]]. The $5B valuation represents market pricing of the integrated content-to-product model, where media operates at a loss to generate zero marginal cost customer acquisition for high-margin CPG products.
|
||||
Beast Industries provides enterprise-scale validation of [[the media attractor state is community-filtered IP with AI-collapsed production costs where content becomes a loss leader for the scarce complements of fandom community and ownership]]. The $5B valuation represents market pricing of the integrated content-to-product model, where media operates at a loss to generate zero marginal cost customer acquisition for high-margin CPG products.
|
||||
Loading…
Reference in a new issue